Navigation Links
AspenBio Pharma Announces Closing of Public Offering of 1,946,000 Shares of Common Stock
Date:11/20/2012

CASTLE ROCK, Colo., Nov. 20, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share. After underwriting discounts and commissions and estimated offering expenses, the Company received net proceeds from the offering of approximately $3.7 million. AspenBio Pharma has also granted the underwriters a 45-day option to purchase up to an additional 291,900 shares of common stock to cover over-allotments, if any.

AspenBio intends to use the net proceeds from this offering for general corporate purposes, including conducting a clinical trial for its blood-based appendicitis test and for working capital purposes.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

A registration statement on Form S-3 relating to the shares was filed with the Securities and Exchange Commission and was declared effective on July 27, 2011. A final prospectus supplement relating to the offering has been filed with the SEC and is available on the SEC's web site at http://www.sec.gov. Copies of the final prospectus may be obtained from the offices of Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY, 10019, telephone: 212-813-1010 or email: prospectus@aegiscap.com, or from the above-mentioned SEC website.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

About AspenBio Pharma and AppyScore

AspenBio
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AspenBio Pharma Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock
2. AspenBio Pharma Announces Proposed Public Offering
3. AspenBio Pharma Begins Training Hospital Sites for Pivotal Clinical Trial
4. AspenBio Pharma to Provide Shareholders with Business Update
5. AspenBio Pharma Executes Worldwide License Agreement for its Animal Health Assets
6. AspenBio Pharma Engages Tiberend Strategic Advisors as Investor and Public Relations Agency of Record
7. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
8. Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board
9. Isis Pharmaceuticals To Present At The 24th Annual Piper Jaffray Healthcare Conference
10. ShangPharma Announces Third Quarter 2012 Results
11. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  MedScope ( www.medscope.org ), ... nominated for a 2015 Connected World magazine ... Response System (mPERS), that can be used anywhere, anytime. ... partner.  In nominating MedScope, Landon ...
(Date:1/23/2015)... , Jan. 23, 2015  HyGreen, Inc., a leader in ... partnership with RCA Medical, a subsidiary of Ascendis Health ... Each year, hundreds of millions of patients ... as organisms are transmitted from patient to patient via ...
(Date:1/23/2015)... , Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), ... equipment for all forms of sports, including extreme motor ... brace, announced today that the UISP Lega Motociclismo Lombardia, ... all riders to wear a neck brace during its ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... This afternoon the Food and Drug Administration (FDA) Advisory Panel, ... an abortifacient, voted against recommending ANY precautions or labeling that would inform women of ... , , ... Family Research Council,s Director of the Center for Human Dignity, released ...
... June 17 The balance of opportunities and activities in pharmaceutical market ... and partnership. , , , ... be seen as a strategic partner is if you provide interpretation and application of ... you really added as value?" , , ...
Cached Medicine Technology:Pharmaceutical Market Research: A Strategic Business Partner in 2011 2
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release ... for kids with cancer. The Chemo Duck App, available on iTunes ... enjoyable games to help children of all ages living with cancer ... keep kids entertained, educated and at ease while waiting for clinic ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... at the Yorkshire Cancer Research Unit (YCR) at the University ... ultimately triggers the development of prostate cancer // . This ... ,The "parent" stem cell research was carried out ... that cancer stem cells are no different from normal stem ...
... run the risk of either serious complications after undergoing ... research // . The Wake Forest University Baptist Medical ... study aimed at finding out if an independent risk ... to the surgery. ,Heparin is used in ...
... who are about to deliver premature babies, as the babies ... rates are lower // . Annie Janvier and Keith Barrington ... records of about 72 babies who ran the risk of ... came to the conclusion that the conversations that the parents ...
... like food cans, water pipes, dental sealants and milk container ... team guided by Scott Belcher, PhD, at the University of ... 2005 edition that even low level of Bisphenol A (BPA) ... the brain and is also concerned with disease and developmental ...
... Bijoy Khandheria of the Division of Cardiology at Mayo Clinic ... heart will lead to better ways of treating patients. The ... study may also contribute towards heart failure from developing. The ... function of a pump for blood. ,The cardiac ...
... awareness of the dreaded HIV virus, Russia marked the World ... as Miss HIV Positive.// ,The result of the ... Russian health officials say that the event was to showcase ... and are not inferior in any way. However, Ms. Izambayeva ...
Cached Medicine News:Health News:Bisphenol A In Food Containers Has Adverse Effect On Brain Tissue 2
Inquire...
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Medicine Products: